Union workers accepted a package of pay and benefit cuts in exchange for a promise that their jobs are safe for the next two years at troubled Mitsubishi Motors' assembly plant in Normal, officials said.
The deal at Mitsubishi's only North American factory was approved Friday after two days of voting by about 1,500 United Auto Workers members at the plant where about 1,200 workers were laid off two years ago as part of a worldwide revival plan Mitsubishi called its last chance to survive as an automaker. The vote was 663-637.
Many workers grumbled about the concessions as they waited to vote. They complained they were being asked to pay for Mitsubishi's mistakes and called the job guarantees a hollow promise, saying the plant could close despite the company's pledge.
Mitsubishi asked workers for a temporary US$4 an hour pay cut and other wage and benefit concessions as it seeks to recover from mounting debt and slumping sales.
In exchange, the Japanese-based automaker guaranteed no involuntary layoffs and that the nearly 20-year-old factory would stay open during the length of the modified contract, which would run through August 2008.
United Auto Workers negotiators, who hammered out concessions during months of talks with the company, had recommended workers approve the deal "to protect our jobs and guarantee future investment," according to a summary of the proposed contract given to employees on Thursday.
The union says the concessions will save Mitsubishi US$40 million.
Mitsubishi is seeking to reverse three straight years of losses that mounted as sales fell due to recall scandals in Japan and risky financing deals that backfired in the US.
The company's US sales are down 9.5 percent for the year but rose about 5 percent in July as consumers gravitated toward smaller, fuel-efficient cars and away from larger sport utility vehicles.
NOTABLE SHIFT: By 2030, 50% of all laptops would be assembled in Southeast Asia, while Taiwan would still mostly focus on research and development, a report said Global laptop and desktop computer supply chains are expected to shift significantly away from China in the next 10 years, a Market Intelligence & Consulting Institute (MIC, 產業情報研究所) report said. By 2030, only 40 percent of global laptop production would remain in China, said the report, which was released on Thursday. “The reshuffling of the global supply chain will be one of the most important trends in the next 10 years,” the institute said in the report. “In the long run, key component makers will follow laptop assemblers in moving out of China.” The Taipei-based institute predicted most key component makers
Yageo Corp (國巨), the world’s third-largest supplier of multilayer ceramic capacitors, has formed a strategic alliance with Hon Hai Precision Industry Co (鴻海精密) to develop key electronic components for electric vehicles and digital healthcare, it said yesterday. The alliance is to help Yageo boost its revenue from high-end components for vehicles and industrial, medical and aerospace devices, as well as those used in 5G and Internet-of-Things devices, the company said. The companies signed the strategic alliance agreement at Yageo’s headquarters in New Taipei City’s Sindian District (新店). Their cooperation is to start this quarter, the companies said in a joint statement. “Through the cooperation
SUPPLY CONSTRAINTS: The transferred orders might not provide an immediate revenue boost given local chipmakers’ high utilization rates, a senior analyst said Shares of local contract chipmakers yesterday rose as much as the 10 percent daily limit, as investors bet on orders being transferred from Semiconductor Manufacturing International Corp (SMIC, 中芯國際) after the US imposed export restrictions on the Chinese chipmaker. United Microelectronics Corp (UMC, 聯電) shares soared 10 percent to close at NT$27.5 as 380 million shares changed hands on the Taiwan Stock Exchange. UMC is the world’s No. 3 foundry by revenue, followed by SMIC, according to data from market researcher TrendForce Corp (集邦科技). UMC has product and customer portfolios similar to those of SMIC, TrendForce said, adding that UMC offers 14-nanometer and
‘IMPORTANT MILESTONE’: The firm expects to launch the generic of Revlimid in the US after March 2022. It has already launched the product in some European countries Lotus Pharmaceutical Co Ltd (美時化學製藥) has received tentative approval from the US Food and Drug Administration (FDA) for its abbreviated new drug application (ANDA) for lenalidomide, the company said in a statement on Friday. The ANDA approval is for 2.5mg, 5mg, 10mg, 20mg and 25mg capsules of lenalidomide, which is a generic version of blood cancer drug Revlimid developed by Celgene Corp. It is the first product fully developed and manufactured in Lotus’ facilities in Taiwan. Lotus expects to launch the product in the US — based on its patent litigation settlement with Celgene last year — some time after March